Browsing by Author Lord, Sarah (Sally)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 74 < previous   next >
Issue DateTitleAuthor(s)Citation
2017Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survivalDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Fukuoka, Masahiro; Gralla, Richard J; Inoue, Akira; Mitsudomi, Tetsuya; Mok, Tony; Nakagawa, Kazuhiko; Rosell, Rafael Costa; Thongprasert, Sumitra; Tu, Yu-Kang; Wu, Yi-long; Yang, James; Zhou, Caicun; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreGefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival, Journal of the National Cancer Institute, vol.109, 6, 2017,pp 1-13
2010Gene expression alterations in formalin-fixed, paraffin-embedded Barrett's esophagus and esophageal adenocarcinoma tissuesLord, Sarah (Sally); Botelho, Natalia K.; Freeman, Araluen K.; Hayward, Nicholas K; Lord, Reginald V. N.; Nancarrow, Derek J.; Schneiders, Fiona I.; Tyagi, Sonika; Whiteman, David C.; NH&MRC Clinical Trials CentreGene expression alterations in formalin-fixed, paraffin-embedded Barrett's esophagus and esophageal adenocarcinoma tissues, Cancer Biology and Therapy, vol.10, 2, 2010,pp 172-179
2015High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and AdenocarcinomaLord, Sarah (Sally); Bobryshev, Yuri Veniaminovich; Botelho, Natalia K; Falkenback, Dan; Fisher, Oliver M; Freeman, Araluen K; Levert-Mignon, Angelique J; Lord, Reginald V; Thomas, Melissa L; Wettstein, Antony; Whiteman, David; NH&MRC Clinical Trials CentreHigh Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma, Annals of Surgical Oncology, vol.22, 7, 2015,pp 2431-2438
2010Historical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias.Coates, Alan; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Stockler, Martin; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreHistorical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias., European Journal of Cancer, vol.46, 3,pp 541-548
2015Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trialGebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Ferrero, A.; Friedlander, Michael; Grunewald, Tami; Hardy-Bessard, Anne Claire; Harter, Philipp; Heywood, M; Pujade-Lauraine, Eric; Scambia, G; Schauer, C; Sehouli, Jalid; Vergote, Ignace; Woie, Kathrine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreImpact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial, Gynecologic Oncology, vol.136, 1, 2015,pp 18-24
2015Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisDing, Pei Ni; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Pavlakis, Nick; Gralla, Richard J; Inoue, Akira; Links, Matthew; Mitsudomi, Tetsuya; Rosell, Rafael Costa; Wu, Yi-long; Yang, James Chic-Hsin; Zhou, Ci-Xiang; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: MedicineImpact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis, Journal of Clinical Oncology, vol.33, 17, 2015,pp 1958-1965
2012Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosisGebski, Val; Houssami, Nehmat; Kiely, Belinda; Lord, Sarah (Sally); Marinovich, Luke; Wilcken, Nicholas; Crossing, Sally; Gattellari, Melina; Patterson, Jillian; Roder, David; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis, Medical Journal of Australia, vol.196, 11, 2012,pp 688-692
2014Increased intraoperative epidural pressure in lumbar spinal stenosis patients with a positive nerve root sedimentation signLord, Sarah (Sally); Staub, Lukas; Barz, Thomas; Lange, Jorn; Melloh, Markus; Merk, Harry; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreIncreased intraoperative epidural pressure in lumbar spinal stenosis patients with a positive nerve root sedimentation sign, European Spine Journal, vol.23, 5, 2014,pp 985-990
2009Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?Lord, Sarah (Sally); Staub, Lukas; Alberio, Lorenzo; Beran, Dominik; Deplazes, Marcus; Greif, Robert; Theiler, Lorenz; Urwyler, Natalie; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreIs perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?, Thrombosis and Haemostasis, vol.102, 4, 2009,pp 779-786
2013A KT intervention including the evidence alert system to improve clinician's evidence-based practice behavior-a cluster randomized controlled trialLord, Sarah (Sally); Campbell, Lanie; McIntyre, Sarah; Novak, Iona; School of Public Health: NH&MRC Clinical Trials CentreA KT intervention including the evidence alert system to improve clinician's evidence-based practice behavior-a cluster randomized controlled trial, Implementation Science, vol.8, 1, 2013,pp 1-15
2012Linking the evidence: intermediate outcomes in medical test assessmentsDyer, Suzanne; Lord, Sarah (Sally); Simes, Robert John; Staub, Lukas; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLinking the evidence: intermediate outcomes in medical test assessments, International Journal of Technology Assessment in Health Care, vol.28, 1, 2012,pp 52-58
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159